Pharming (PHAR) Free Cash Flow (2020 - 2022)
Historic Free Cash Flow for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$31.4 million.
- Pharming's Free Cash Flow fell 79528.66% to -$31.4 million in Q2 2023 from the same period last year, while for Mar 2024 it was -$31.4 million, marking a year-over-year decrease of 17185030.06%. This contributed to the annual value of -$800000.0 for FY2024, which is 4432.85% up from last year.
- According to the latest figures from Q2 2023, Pharming's Free Cash Flow is -$31.4 million, which was down 79528.66% from $817000.0 recorded in Q4 2022.
- In the past 5 years, Pharming's Free Cash Flow registered a high of $21.8 million during Q2 2021, and its lowest value of -$31.4 million during Q2 2023.
- Its 5-year average for Free Cash Flow is $1.6 million, with a median of $817000.0 in 2022.
- As far as peak fluctuations go, Pharming's Free Cash Flow surged by 897926.97% in 2022, and later tumbled by 79528.66% in 2023.
- Pharming's Free Cash Flow (Quarter) stood at $2.6 million in 2019, then crashed by 96.48% to $92123.5 in 2020, then plummeted by 49.13% to $46859.3 in 2021, then surged by 1643.52% to $817000.0 in 2022, then tumbled by 3945.78% to -$31.4 million in 2023.
- Its Free Cash Flow stands at -$31.4 million for Q2 2023, versus $817000.0 for Q4 2022 and -$5.3 million for Q3 2022.